What does ocadusertib — deferred revenue mean?

Represents payments received from collaboration partners for a specific drug program that have not yet been recognized as revenue because performance obligations remain unfulfilled. This liability reflects future services or milestones that the company must deliver to earn the revenue. It provides insight into the timing of future revenue recognition and the status of ongoing contractual obligations.

Rigel Pharmaceuticals RIGL ocadusertib — Deferred Revenue

Similar metrics at other companies

FDMTDeferred Revenue — Deferred Revenue

$2.49M—

LZBDeferred Revenue

$34.91M+7.1%

IBT

IBTADeferred revenue — Deferred Revenue

$2.7M-51.8%

SDGRDrug discovery — Deferred Revenue

$42.36M-5.6%

NUVBRoyalty Revenue — Deferred Revenue

$300K—

SIGOther Deferred Revenue — Contract with Customer, Liability

$86.5M+6.9%

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's ocadusertib — deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's ocadusertib — deferred revenue?: Rigel Pharmaceuticals (RIGL) reported ocadusertib — deferred revenue of $0 in Q1 2026.
What does ocadusertib — deferred revenue mean?: Represents payments received from collaboration partners for a specific drug program that have not yet been recognized as revenue because performance obligations remain unfulfilled. This liability reflects future services or milestones that the company must deliver to earn the revenue. It provides insight into the timing of future revenue recognition and the status of ongoing contractual obligations.